NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/07/2024
Voltar para busca
Dado oficial do USPTO
SYNVANTAGE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SYNVANTAGE
ST13
US500000090100048Classe
1, 5, 42, 44
Pedido
90100048
Registro
7452470
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
23/07/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
07/08/2020
Data de registro
23/07/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/07/2024
Última transação
23/07/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Karnataka, IN
Examinador
SNYDER, NELSON B
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Syngene International Limited
Representantes
Mark A. Watkins VORYS, SATRER, SEYMOUR AND PEASE LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in biotechnological manufacturing processes and product development; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Chemicals for use in industry and science; Biological preparations for use in industry and science; Enzymes derived from biotechnological processes for use in industry; enzyme substrates; enzyme stabilizers; Enzymes for scientific and research purposes; biomedical compoundspeptide substrates used in analyzing and detecting certain toxins for laboratoryresearchclinical or medical laboratory use; chitosans for industrial purposes; aldehydes; chromatography chemicals; Stem cells for research purposes; cells for scientificlaboratory or medical research; Reagents for scientific and research use; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; Protein for industrial use; Proteins for use in manufacture; specialty chemicalschemical additives for general industrial use in the manufacture of a wide variety of goods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; Nucleic acid sequencesother than for medical or veterinary purposes; Reagents for scientific purposes for use in nucleic acid isolation and purification; gelsreagentschemical standardsdyes and trace dyes for electrophoresisother than for medical or veterinary purposes; preparative electrophoresis reagentsother than for medical or veterinary purposes
Classe 5
Autonomic drugs for medical purposes for treatment of diseases and conditions in the fields of oncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Diagnostic preparations for medical or veterinary purposes; Chemical preparations for pharmaceutical or medical purposesfor treating diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Prescription and non-prescription medicinespillstabletscapsulescapletsliquid dropssachets and pharmaceutical preparations for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Dietary supplements for humans and animals; Biological tissue cultures for medical purposes; Biological preparations for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; Pharmaceutical preparations for the treatment of infectious diseases; Bio-logical and biotechnological products pertaining to pharmaceutical and medical industries and formulations thereof for pharmaceutical and medical usepharmaceutical preparations for the treatment of diseases and conditions in the fields of oncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; synthetic peptides for pharmaceutical purposes and for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; imaging agents for magnetic resonance imaging (MRI); nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for the treatment of diseases and conditions involving areasoncologyendocrinology and metabolic diseasescardio vascularneuro musculardentaldermatologicalurologicalnephrologicalimmunologicalgeneticsophthalmologydiabetesmultiple sclerosisacne; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medicalveterinary or pharmaceutical purposes; Protein arrays for medical diagnosis purposes; medicines for veterinary purposes for the treatment of skin allergiesehrlichiosisear infectiondiabeteskennel coughupper respiratory tract infectioncoccidiosisbabesiosisectoparasitesendoparasites; isotopes for medical purposes; chemical preparations for medical purposes for use in DNA analysis; diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Contrast media for in vivo imaging; Contrast agents for use in molecular imaging
Classe 42
Development of pharmaceutical preparations and medicines; Drug discovery services; Pharmaceutical drug development services; Scientific study and research in the fields of medicinethe preventiontreatment and management of illnesshealth care delivery; medical research services; pharmaceutical research services; laboratory research services relating to pharmaceuticals; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Conducting clinical trials for others; biological and chemical research; bacteriological research; Biological research and analysis; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research and development purposes; testing of pharmaceuticals; chemical engineering; scientific study and research in the field of reproductionhusbandrygeneral health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodiesantibody technologyimmunopharmaceuticals and vaccines; designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; toxicology services; toxicity testing for research purposes; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract scientific research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and biological laboratory for research purposes; research and development and consultation related thereto in the field of antibodiesantibody technologychemistryagrochemical pharmaceuticalsbioinformaticsbiomedical devicesbiologicsbiotechnologybiotherapeuticsbiologybiochemical preparationscell lineschemoinformaticgenetics and genetic engineeringgene expression systemsin vitro researchinhalation pharmaceuticalsmolecular sciencesmicro organismsnutritionophthalmic preparationspharmacogeneticspharmacokineticspharmacologypharmaceuticalspolymerspeptide synthesisproteinsolid state characterization; scientific and technological servicesscientific researchdevelopmentanalysistestingtechnological servicesscientific researchdevelopmentanalysistestingengineeringextractionsynthesispurification and production in the field of antibodiesactive pharmaceutical ingredients (API)biomoleculescell bank characterizationchiralitychromosome aberrationclinical chemistrycloning vectorcyclotidesDNAflow cytometrygas chromatography mass spectrometrygeneimmuno-pharmaceuticalsin vitro irritationlarge moleculeliquid chromatography mass spectrometrymicrobialsmonomersnanoparticlesnatural productspeptidesproteinsRNAsupercritical fluid chromatographysmall molecules and vaccines; Laboratory servicesimaging core lab services
Classe 44
Drugalcohol and DNA screening for medical purposes; medical services; medical and pharmaceutical consultation; Medical diagnostic testingmonitoring and reporting services; pathology services for medical and diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
23/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/05/2024
PUBO
PUBLISHED FOR OPPOSITION
07/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/04/2024
ATRV
ATTORNEY REVIEW COMPLETED
03/04/2024
OTHE
CASE RETURNED TO EXAMINATION
03/04/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
03/04/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/04/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
01/04/2024
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
27/03/2024
PILM
PETITION INQUIRY LETTER ISSUED
06/03/2024
APET
ASSIGNED TO PETITION STAFF
05/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/12/2023
EX5G
SOU EXTENSION 5 GRANTED
04/12/2023
EXT5
SOU EXTENSION 5 FILED
01/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/06/2023
EX4G
SOU EXTENSION 4 GRANTED
01/06/2023
EXT4
SOU EXTENSION 4 FILED
01/06/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/06/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2022
EX3G
SOU EXTENSION 3 GRANTED
30/11/2022
EXT3
SOU EXTENSION 3 FILED
30/11/2022
EEXT
SOU TEAS EXTENSION RECEIVED
30/11/2022
CORV
REVIEW OF CORRESPONDENCE COMPLETE
20/10/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/10/2022
44EP
44(e) PETITION - RECEIVED
30/09/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
30/09/2022
ATRV
ATTORNEY REVIEW COMPLETED
29/07/2022
DOCK
ASSIGNED TO EXAMINER
20/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/07/2022
NREV
NOTICE OF REVIVAL - E-MAILED
08/07/2022
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
08/07/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
08/07/2022
APET
ASSIGNED TO PETITION STAFF
08/07/2022
EX2G
SOU EXTENSION 2 GRANTED
08/07/2022
PGEX
PETITION GRANTED - EXTENSION REQUEST FILED
08/07/2022
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
06/07/2022
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
05/07/2022
ABN6
ABANDONMENT - NO USE STATEMENT FILED
04/07/2022
APET
ASSIGNED TO PETITION STAFF
22/06/2022
EXT2
SOU EXTENSION 2 FILED
01/06/2022
44EP
44(e) PETITION - RECEIVED
31/05/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
31/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/12/2021
EX1G
SOU EXTENSION 1 GRANTED
30/11/2021
EXT1
SOU EXTENSION 1 FILED
30/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
30/11/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2021
PUBO
PUBLISHED FOR OPPOSITION
06/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/03/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/03/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/03/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/11/2020
GNRT
NON-FINAL ACTION E-MAILED
10/11/2020
CNRT
NON-FINAL ACTION WRITTEN
10/11/2020
DOCK
ASSIGNED TO EXAMINER
04/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2020
NWAP
NEW APPLICATION ENTERED
11/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SYNVANTAGE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.